Triple negative breast cancer (TNBC) is characterized by the lack of estrogen and
progesterone receptor expression and lacks HER2 overexpression or gene amplification. It …

Approximately one‐half of individuals with cancer face personal economic burdens
associated with the disease and its treatment, a problem known as financial toxicity (FT). FT …

Background: Patients with cancer experience financial toxicity from the costs of treatment, as
well as material and psychologic stress related to this burden. A synthesized understanding …

Importance To our knowledge, there is no consensus regarding differences in treatment and
mortality between non-Hispanic African American and non-Hispanic White women with triple …

Financial toxicity describes the financial burden and distress that can arise for patients, and
their family members, as a result of cancer treatment. It includes direct out-of-pocket costs for …

The growth of artificial intelligence in promoting healthcare is rapidly progressing.
Notwithstanding its promising nature, however, AI in healthcare embodies certain ethical …

Background Financial toxicity has traditionally been attributed to the rising costs of cancer
care. As ability to work impacts one's financial situation, limited employment and reduced …

Background: Cancer has substantial health, quality-of-life, and economic impacts. Screening
may decrease cancer mortality and treatment costs, but the cost of screening in the United …

Background: With rising costs of cancer care, this study aims to estimate the prevalence of,
and factors associated with, medical financial hardship intensity and financial sacrifices due …

Cancer survivors spend more out of pocket (OOP) for medical care than their counterparts
without a cancer history, a pattern that persists many years after cancer diagnosis and …